Annual Operating Profit
-$137.85 M
-$42.63 M-44.78%
December 31, 2023
Summary
- As of February 20, 2025, AVDL annual operating income is -$137.85 million, with the most recent change of -$42.63 million (-44.78%) on December 31, 2023.
- During the last 3 years, AVDL annual operating profit has fallen by -$101.19 million (-276.01%).
- AVDL annual operating profit is now -235.52% below its all-time high of $101.72 million, reached on December 31, 2015.
Performance
AVDL Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Profit
-$327.00 K
+$12.41 M+97.43%
September 30, 2024
Summary
- As of February 20, 2025, AVDL quarterly operating income is -$327.00 thousand, with the most recent change of +$12.41 million (+97.43%) on September 30, 2024.
- Over the past year, AVDL quarterly operating profit has increased by +$24.57 million (+98.69%).
- AVDL quarterly operating profit is now -101.08% below its all-time high of $30.30 million, reached on September 30, 2015.
Performance
AVDL Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Operating Profit
-$64.00 M
+$34.78 M+35.21%
September 30, 2024
Summary
- As of February 20, 2025, AVDL TTM operating income is -$64.00 million, with the most recent change of +$34.78 million (+35.21%) on September 30, 2024.
- Over the past year, AVDL TTM operating profit has increased by +$73.85 million (+53.57%).
- AVDL TTM operating profit is now -162.80% below its all-time high of $101.92 million, reached on December 31, 2015.
Performance
AVDL TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Profit Formula
Operating Profit = Gross Profit − Operating Expenses
AVDL Operating Profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -44.8% | +98.7% | +53.6% |
| 3 y3 years | -276.0% | +99.3% | +45.8% |
| 5 y5 years | -127.7% | +99.3% | +45.8% |
AVDL Operating Profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -61.0% | at low | at high | +99.3% | at high | +53.6% |
| 5 y | 5-year | -719.3% | at low | at high | +99.3% | -303.0% | +53.6% |
| alltime | all time | -235.5% | at low | -101.1% | +99.3% | -162.8% | +53.6% |
Avadel Pharmaceuticals Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$327.00 K(-97.4%) | -$64.00 M(-35.2%) |
| Jun 2024 | - | -$12.74 M(-51.1%) | -$98.79 M(-27.1%) |
| Mar 2024 | - | -$26.04 M(+4.6%) | -$135.59 M(-1.6%) |
| Dec 2023 | -$137.85 M(+44.8%) | -$24.90 M(-29.1%) | -$137.85 M(+1.2%) |
| Sep 2023 | - | -$35.11 M(-29.1%) | -$136.16 M(+15.3%) |
| Jun 2023 | - | -$49.54 M(+75.1%) | -$118.08 M(+24.4%) |
| Mar 2023 | - | -$28.30 M(+21.9%) | -$94.89 M(-0.3%) |
| Dec 2022 | -$95.22 M(+11.2%) | -$23.22 M(+36.3%) | -$95.22 M(+0.1%) |
| Sep 2022 | - | -$17.03 M(-35.4%) | -$95.14 M(-8.3%) |
| Jun 2022 | - | -$26.34 M(-8.0%) | -$103.77 M(+4.4%) |
| Mar 2022 | - | -$28.63 M(+23.7%) | -$99.36 M(+16.1%) |
| Dec 2021 | -$85.60 M(+133.5%) | -$23.14 M(-9.8%) | -$85.60 M(+11.6%) |
| Sep 2021 | - | -$25.66 M(+17.0%) | -$76.72 M(+17.9%) |
| Jun 2021 | - | -$21.94 M(+47.6%) | -$65.05 M(+36.5%) |
| Mar 2021 | - | -$14.86 M(+4.2%) | -$47.66 M(+30.0%) |
| Dec 2020 | -$36.66 M(+117.9%) | -$14.26 M(+1.9%) | -$36.66 M(+24.5%) |
| Sep 2020 | - | -$13.99 M(+207.6%) | -$29.45 M(+72.1%) |
| Jun 2020 | - | -$4.55 M(+17.8%) | -$17.11 M(+7.7%) |
| Mar 2020 | - | -$3.86 M(-45.2%) | -$15.88 M(-5.6%) |
| Dec 2019 | -$16.83 M(-72.2%) | -$7.04 M(+325.9%) | -$16.83 M(-30.1%) |
| Sep 2019 | - | -$1.65 M(-50.2%) | -$24.06 M(-44.8%) |
| Jun 2019 | - | -$3.32 M(-30.9%) | -$43.55 M(-22.0%) |
| Mar 2019 | - | -$4.80 M(-66.4%) | -$55.85 M(-7.8%) |
| Dec 2018 | -$60.55 M(-199.3%) | -$14.28 M(-32.5%) | -$60.55 M(+16.6%) |
| Sep 2018 | - | -$21.14 M(+35.3%) | -$51.92 M(+243.6%) |
| Jun 2018 | - | -$15.62 M(+64.4%) | -$15.11 M(-167.2%) |
| Mar 2018 | - | -$9.50 M(+68.4%) | $22.48 M(-63.2%) |
| Dec 2017 | $61.01 M(+37.7%) | -$5.64 M(-136.0%) | $61.01 M(-23.8%) |
| Sep 2017 | - | $15.66 M(-28.7%) | $80.01 M(+15.9%) |
| Jun 2017 | - | $21.96 M(-24.3%) | $69.01 M(+16.2%) |
| Mar 2017 | - | $29.02 M(+117.2%) | $59.40 M(+34.0%) |
| Dec 2016 | $44.32 M(-56.4%) | $13.36 M(+186.8%) | $44.32 M(-22.9%) |
| Sep 2016 | - | $4.66 M(-62.3%) | $57.48 M(-30.8%) |
| Jun 2016 | - | $12.36 M(-11.4%) | $83.12 M(-17.2%) |
| Mar 2016 | - | $13.95 M(-47.4%) | $100.39 M(-1.5%) |
| Dec 2015 | $101.72 M(-406.8%) | $26.52 M(-12.5%) | $101.92 M(+56.6%) |
| Sep 2015 | - | $30.30 M(+2.2%) | $65.09 M(+151.9%) |
| Jun 2015 | - | $29.63 M(+91.6%) | $25.84 M(-344.1%) |
| Mar 2015 | - | $15.47 M(-250.1%) | -$10.59 M(-67.6%) |
| Dec 2014 | -$33.15 M(+29.7%) | -$10.31 M(+15.1%) | -$32.65 M(+10.6%) |
| Sep 2014 | - | -$8.96 M(+31.8%) | -$29.52 M(+12.1%) |
| Jun 2014 | - | -$6.79 M(+3.0%) | -$26.32 M(+4.1%) |
| Mar 2014 | - | -$6.59 M(-8.2%) | -$25.28 M(-1.1%) |
| Dec 2013 | -$25.57 M(+18.5%) | -$7.18 M(+24.7%) | -$25.57 M(+10.0%) |
| Sep 2013 | - | -$5.76 M(+0.1%) | -$23.23 M(+1.3%) |
| Jun 2013 | - | -$5.75 M(-16.3%) | -$22.93 M(-1.7%) |
| Mar 2013 | - | -$6.88 M(+41.8%) | -$23.33 M(+8.1%) |
| Dec 2012 | -$21.58 M(+125.2%) | -$4.85 M(-11.1%) | -$21.58 M(+13.5%) |
| Sep 2012 | - | -$5.46 M(-11.3%) | -$19.01 M(+54.4%) |
| Jun 2012 | - | -$6.15 M(+20.0%) | -$12.31 M(+25.4%) |
| Mar 2012 | - | -$5.13 M(+125.1%) | -$9.82 M(+2.5%) |
| Dec 2011 | -$9.58 M(-2.6%) | -$2.28 M(-283.6%) | -$9.58 M(+82.2%) |
| Sep 2011 | - | $1.24 M(-133.9%) | -$5.26 M(-45.4%) |
| Jun 2011 | - | -$3.65 M(-25.3%) | -$9.63 M(-10.0%) |
| Mar 2011 | - | -$4.89 M(-339.2%) | -$10.70 M(+8.8%) |
| Dec 2010 | -$9.84 M | $2.04 M(-165.4%) | -$9.84 M(-44.8%) |
| Sep 2010 | - | -$3.13 M(-33.9%) | -$17.82 M(-1.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2010 | - | -$4.73 M(+17.3%) | -$18.03 M(+6.6%) |
| Mar 2010 | - | -$4.03 M(-32.1%) | -$16.92 M(+44.0%) |
| Dec 2009 | -$11.75 M(-10.8%) | -$5.94 M(+77.9%) | -$11.75 M(+213.2%) |
| Sep 2009 | - | -$3.34 M(-7.7%) | -$3.75 M(-25.4%) |
| Jun 2009 | - | -$3.62 M(-417.6%) | -$5.03 M(-29.6%) |
| Mar 2009 | - | $1.14 M(-44.8%) | -$7.15 M(-45.8%) |
| Dec 2008 | -$13.18 M(-67.7%) | $2.06 M(-144.7%) | -$13.18 M(-43.4%) |
| Sep 2008 | - | -$4.62 M(-19.5%) | -$23.30 M(-16.6%) |
| Jun 2008 | - | -$5.73 M(+17.1%) | -$27.95 M(-22.8%) |
| Mar 2008 | - | -$4.89 M(-39.3%) | -$36.23 M(-11.3%) |
| Dec 2007 | -$40.85 M(+5.2%) | -$8.06 M(-13.0%) | -$40.85 M(-1.0%) |
| Sep 2007 | - | -$9.26 M(-33.9%) | -$41.26 M(-3.2%) |
| Jun 2007 | - | -$14.01 M(+47.1%) | -$42.64 M(+11.6%) |
| Mar 2007 | - | -$9.52 M(+12.4%) | -$38.21 M(-1.6%) |
| Dec 2006 | -$38.84 M(-4.7%) | -$8.47 M(-20.5%) | -$38.84 M(-6.3%) |
| Sep 2006 | - | -$10.64 M(+11.0%) | -$41.46 M(-3.6%) |
| Jun 2006 | - | -$9.59 M(-5.5%) | -$43.00 M(-0.8%) |
| Mar 2006 | - | -$10.14 M(-8.5%) | -$43.33 M(+6.3%) |
| Dec 2005 | -$40.77 M(-561.4%) | -$11.09 M(-8.9%) | -$40.77 M(+65.3%) |
| Sep 2005 | - | -$12.18 M(+22.8%) | -$24.66 M(+138.0%) |
| Jun 2005 | - | -$9.92 M(+30.8%) | -$10.36 M(+309.6%) |
| Mar 2005 | - | -$7.58 M(-251.0%) | -$2.53 M(-128.6%) |
| Dec 2004 | $8.84 M(-288.0%) | $5.02 M(+137.1%) | $8.84 M(+169.7%) |
| Sep 2004 | - | $2.12 M(-201.5%) | $3.28 M(-662.9%) |
| Jun 2004 | - | -$2.08 M(-155.1%) | -$582.00 K(+144.5%) |
| Mar 2004 | - | $3.78 M(-800.7%) | -$238.00 K(-96.3%) |
| Dec 2003 | -$4.70 M(+2007.2%) | -$540.00 K(-69.0%) | -$6.44 M(-31.3%) |
| Sep 2003 | - | -$1.74 M(0.0%) | -$9.37 M(+73.3%) |
| Jun 2003 | - | -$1.74 M(-28.0%) | -$5.41 M(-506.4%) |
| Mar 2003 | - | -$2.42 M(-30.4%) | $1.33 M(-84.0%) |
| Dec 2002 | -$223.00 K(-92.9%) | -$3.47 M(-256.3%) | $8.31 M(+8046.1%) |
| Sep 2002 | - | $2.22 M(-55.5%) | $102.00 K(-79.8%) |
| Jun 2002 | - | $5.00 M(+9.6%) | $504.00 K(-124.4%) |
| Mar 2002 | - | $4.56 M(-139.0%) | -$2.06 M(-34.6%) |
| Dec 2001 | -$3.15 M(-80.4%) | -$11.68 M(-545.0%) | -$3.15 M(-79.8%) |
| Sep 2001 | - | $2.63 M(+7.9%) | -$15.58 M(+2.5%) |
| Jun 2001 | - | $2.43 M(-29.8%) | -$15.21 M(+2.8%) |
| Mar 2001 | - | $3.47 M(-114.4%) | -$14.80 M(-9.1%) |
| Dec 2000 | -$16.11 M(+130.1%) | -$24.11 M(-903.6%) | -$16.28 M(+407.6%) |
| Sep 2000 | - | $3.00 M(+5.6%) | -$3.21 M(-29.0%) |
| Jun 2000 | - | $2.84 M(+43.4%) | -$4.52 M(-28.4%) |
| Mar 2000 | - | $1.98 M(-118.0%) | -$6.32 M(-9.7%) |
| Dec 1999 | -$7.00 M(-24.7%) | -$11.03 M(-753.6%) | -$7.00 M(-41.0%) |
| Sep 1999 | - | $1.69 M(+61.4%) | -$11.86 M(+0.1%) |
| Jun 1999 | - | $1.05 M(-19.5%) | -$11.85 M(+16.2%) |
| Mar 1999 | - | $1.30 M(-108.2%) | -$10.19 M(-28.7%) |
| Dec 1998 | -$9.29 M(+3.2%) | -$15.89 M(-1034.8%) | -$14.29 M(+18.1%) |
| Sep 1998 | - | $1.70 M(-37.0%) | -$12.10 M(-4.0%) |
| Jun 1998 | - | $2.70 M(-196.4%) | -$12.60 M(-10.0%) |
| Mar 1998 | - | -$2.80 M(-79.6%) | -$14.00 M(+53.8%) |
| Dec 1997 | -$9.00 M(0.0%) | -$13.70 M(-1241.7%) | -$9.10 M(+12.3%) |
| Sep 1997 | - | $1.20 M(-7.7%) | -$8.10 M(-5.8%) |
| Jun 1997 | - | $1.30 M(-38.1%) | -$8.60 M(-4.4%) |
| Mar 1997 | - | $2.10 M(-116.5%) | -$9.00 M(-26.2%) |
| Dec 1996 | -$9.00 M | -$12.70 M(-1914.3%) | -$12.20 M(-2540.0%) |
| Sep 1996 | - | $700.00 K(-22.2%) | $500.00 K(-350.0%) |
| Jun 1996 | - | $900.00 K(-181.8%) | -$200.00 K(-81.8%) |
| Mar 1996 | - | -$1.10 M | -$1.10 M |
FAQ
- What is Avadel Pharmaceuticals annual operating income?
- What is the all time high annual operating profit for Avadel Pharmaceuticals?
- What is Avadel Pharmaceuticals annual operating profit year-on-year change?
- What is Avadel Pharmaceuticals quarterly operating income?
- What is the all time high quarterly operating profit for Avadel Pharmaceuticals?
- What is Avadel Pharmaceuticals quarterly operating profit year-on-year change?
- What is Avadel Pharmaceuticals TTM operating income?
- What is the all time high TTM operating profit for Avadel Pharmaceuticals?
- What is Avadel Pharmaceuticals TTM operating profit year-on-year change?
What is Avadel Pharmaceuticals annual operating income?
The current annual operating profit of AVDL is -$137.85 M
What is the all time high annual operating profit for Avadel Pharmaceuticals?
Avadel Pharmaceuticals all-time high annual operating income is $101.72 M
What is Avadel Pharmaceuticals annual operating profit year-on-year change?
Over the past year, AVDL annual operating income has changed by -$42.63 M (-44.78%)
What is Avadel Pharmaceuticals quarterly operating income?
The current quarterly operating profit of AVDL is -$327.00 K
What is the all time high quarterly operating profit for Avadel Pharmaceuticals?
Avadel Pharmaceuticals all-time high quarterly operating income is $30.30 M
What is Avadel Pharmaceuticals quarterly operating profit year-on-year change?
Over the past year, AVDL quarterly operating income has changed by +$24.57 M (+98.69%)
What is Avadel Pharmaceuticals TTM operating income?
The current TTM operating profit of AVDL is -$64.00 M
What is the all time high TTM operating profit for Avadel Pharmaceuticals?
Avadel Pharmaceuticals all-time high TTM operating income is $101.92 M
What is Avadel Pharmaceuticals TTM operating profit year-on-year change?
Over the past year, AVDL TTM operating income has changed by +$73.85 M (+53.57%)